| Year |
Citation |
Score |
| 2023 |
Marie N, Noble F. Oxycodone, an opioid like the others? Frontiers in Psychiatry. 14: 1229439. PMID 38152360 DOI: 10.3389/fpsyt.2023.1229439 |
0.359 |
|
| 2023 |
Requana Aradas A, Djaboub Y, McCort-Tranchepain I, Hajasova Z, Clémenceau L, Canestrelli C, Mann A, Schulz S, Delaval A, Acher F, Massotte D, Noble F, Marie N. Activation of the mu-delta opioid receptor heteromers blocks morphine rewarding effects. The International Journal of Neuropsychopharmacology. PMID 37343217 DOI: 10.1093/ijnp/pyad032 |
0.389 |
|
| 2021 |
Noble F, Marie N. Biased Opioid Ligands: Revolution or Evolution? Frontiers in Pain Research (Lausanne, Switzerland). 2: 722820. PMID 35295469 DOI: 10.3389/fpain.2021.722820 |
0.325 |
|
| 2020 |
Busserolles J, Soussia IB, Pouchol L, Marie N, Meleine M, Devilliers M, Judon C, Schopp J, Clémenceau L, Poupon L, Chapuy E, Richard S, Noble F, Lesage F, Ducki S, et al. TREK-1 channel activation as a new analgesic strategy devoid of opioid adverse effects. British Journal of Pharmacology. PMID 32851651 DOI: 10.1111/Bph.15243 |
0.466 |
|
| 2020 |
Paizanis E, Crotti M, Petit A, Règue M, Beray-Berthat V, Noble F, Lanfumey L, Mongeau R. Effects of Alcohol and Cocaine in a Mutant Mouse Model of Predisposition to Post-Traumatic Stress Disorder. Frontiers in Pharmacology. 11: 623. PMID 32477119 DOI: 10.3389/Fphar.2020.00623 |
0.328 |
|
| 2019 |
Noble F. [Neural circuits and neurotransmitters involved in the effects of psychoactive drugs - State of the art with a focus on cocaine]. Biologie Aujourd'Hui. 213: 141-145. PMID 31829934 DOI: 10.1051/Jbio/2019013 |
0.319 |
|
| 2019 |
Geoffroy H, Canestrelli C, Marie N, Noble F. Morphine-induced dendritic spine remodeling in rat nucleus accumbens is corticosterone dependent. The International Journal of Neuropsychopharmacology. PMID 30915438 DOI: 10.1093/Ijnp/Pyz014 |
0.429 |
|
| 2018 |
Noble F, Marie N. Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine. Frontiers in Psychiatry. 9: 742. PMID 30713510 DOI: 10.3389/Fpsyt.2018.00742 |
0.466 |
|
| 2018 |
Marie N, Canestrelli C, Noble F. Role of pharmacokinetic and pharmacodynamic parameters in neuroadaptations induced by drugs of abuse, with a focus on opioids and psychostimulants. Neuroscience and Biobehavioral Reviews. PMID 30340773 DOI: 10.1016/J.Neubiorev.2018.06.006 |
0.408 |
|
| 2018 |
Hajasova Z, Canestrelli C, Acher F, Noble F, Marie N. Role of mGlu7 receptor in morphine rewarding effects is uncovered by a novel orthosteric agonist. Neuropharmacology. PMID 29307544 DOI: 10.1016/J.Neuropharm.2018.01.002 |
0.463 |
|
| 2017 |
Kelaï S, Ramoz N, Moalic JM, Noble F, Mechawar N, Imbeaud S, Turecki G, Simonneau M, Gorwood P, Maussion G. Netrin G1: its downregulation in the nucleus accumbens of cocaine-conditioned mice and genetic association in human cocaine dependence. Addiction Biology. PMID 28074533 DOI: 10.1111/Adb.12485 |
0.31 |
|
| 2017 |
Geoffroy H, Marie N, Noble F. BDNF alterations in nucleus accumbens shell during morphine withdrawal European Neuropsychopharmacology. 27: S1064-S1065. DOI: 10.1016/S0924-977X(17)31856-4 |
0.413 |
|
| 2016 |
Lenoir M, Noble F. [What brings neurobiology to addictions?] Presse Medicale (Paris, France : 1983). PMID 27020520 DOI: 10.1016/J.Lpm.2016.02.021 |
0.303 |
|
| 2016 |
Hajasova Z, Canestrelli C, Rigault D, Brabet I, Goudet C, Acher F, Noble F, Marie N. The mGlu7 receptor: a new target in the therapy of cocaine and opiates addiction? European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31812-0 |
0.324 |
|
| 2015 |
Posa L, Accarie A, Noble F, Marie N. Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26390873 DOI: 10.1093/Ijnp/Pyv108 |
0.729 |
|
| 2015 |
Noble F, Lenoir M, Marie N. The opioid receptors as targets for drug abuse medication. British Journal of Pharmacology. 172: 3964-79. PMID 25988826 DOI: 10.1111/Bph.13190 |
0.493 |
|
| 2015 |
Geoffroy HA, Puig S, Benturquia N, Noble F. Temporal regulation of peripheral BDNF levels during cocaine and morphine withdrawal: comparison with a natural reward. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25522421 DOI: 10.1093/Ijnp/Pyu088 |
0.363 |
|
| 2015 |
Allouche S, Le Marec T, Coquerel A, Noble F, Marie N. Striatal dopamine D1 and D2 receptors are differentially regulated following buprenorphine or methadone treatment. Psychopharmacology. 232: 1527-33. PMID 25358852 DOI: 10.1007/S00213-014-3785-X |
0.432 |
|
| 2014 |
Allouche S, Noble F, Marie N. Opioid receptor desensitization: mechanisms and its link to tolerance. Frontiers in Pharmacology. 5: 280. PMID 25566076 DOI: 10.3389/Fphar.2014.00280 |
0.411 |
|
| 2014 |
Seleman M, Chapy H, Cisternino S, Courtin C, Smirnova M, Schlatter J, Chiadmi F, Scherrmann JM, Noble F, Marie-Claire C. Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties. Psychopharmacology. 231: 3139-49. PMID 24705903 DOI: 10.1007/S00213-014-3490-9 |
0.342 |
|
| 2014 |
Canestrelli C, Marie N, Noble F. Rewarding or aversive effects of buprenorphine/naloxone combination (Suboxone) depend on conditioning trial duration. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1367-73. PMID 24606726 DOI: 10.1017/S146114571400025X |
0.48 |
|
| 2014 |
Puig S, Marie N, Benturquia N, Noble F. Influence of cocaine administration patterns on dopamine receptor regulation. Psychopharmacology. 231: 3131-7. PMID 24557089 DOI: 10.1007/S00213-014-3488-3 |
0.36 |
|
| 2013 |
Belkaï E, Crété D, Courtin C, Noble F, Marie-Claire C. Comparison of the transcriptional responses induced by acute morphine, methadone and buprenorphine. European Journal of Pharmacology. 711: 10-8. PMID 23624329 DOI: 10.1016/J.Ejphar.2013.04.015 |
0.483 |
|
| 2013 |
Mohammed W, Alhaddad H, Marie N, Tardy F, Lamballais F, Risède P, Noble F, Baud FJ, Mégarbane B. Comparison of tolerance to morphine-induced respiratory and analgesic effects in mice. Toxicology Letters. 217: 251-9. PMID 23296104 DOI: 10.1016/J.Toxlet.2012.12.021 |
0.487 |
|
| 2013 |
Allouche S, Le Marec T, Noble F, Marie N. Different patterns of administration modulate propensity of methadone and buprenorphine to promote locomotor sensitization in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 40: 286-91. PMID 23103550 DOI: 10.1016/J.Pnpbp.2012.10.013 |
0.449 |
|
| 2012 |
Puig S, Noble F, Benturquia N. Short- and long-lasting behavioral and neurochemical adaptations: relationship with patterns of cocaine administration and expectation of drug effects in rats. Translational Psychiatry. 2: e175. PMID 23092979 DOI: 10.1038/Tp.2012.103 |
0.358 |
|
| 2012 |
Marie N, Noble F. [Drug dependence: Progress in neurobiology and perspectives in therapeutics]. Presse MéDicale (Paris, France : 1983). 41: 1259-70. PMID 23040953 DOI: 10.1016/J.Lpm.2012.07.023 |
0.325 |
|
| 2012 |
Faget L, Erbs E, Le Merrer J, Scherrer G, Matifas A, Benturquia N, Noble F, Decossas M, Koch M, Kessler P, Vonesch JL, Schwab Y, Kieffer BL, Massotte D. In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profile. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 7301-10. PMID 22623675 DOI: 10.1523/Jneurosci.0185-12.2012 |
0.423 |
|
| 2012 |
Marie N, Canestrelli C, Noble F. Transfer of neuroplasticity from nucleus accumbens core to shell is required for cocaine reward. Plos One. 7: e30241. PMID 22272316 DOI: 10.1371/Journal.Pone.0030241 |
0.33 |
|
| 2012 |
Noble F, Benturquia N, Crete D, Canestrelli C, Mas Nieto M, Wilson J, Roques BP. Relationship between vulnerability to reinforcing effects of morphine and activity of the endogenous cholecystokinin system in Lewis and Fischer rats. Addiction Biology. 17: 528-38. PMID 21309946 DOI: 10.1111/J.1369-1600.2010.00283.X |
0.424 |
|
| 2011 |
Vorspan F, Guillem E, Bloch V, Bellais L, Sicot R, Noble F, Lepine JP, Gorelick DA. [Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence]. L'EncéPhale. 37: 266-72. PMID 21981886 DOI: 10.1016/J.Encep.2010.12.007 |
0.379 |
|
| 2011 |
Le Marec T, Marie-Claire C, Noble F, Marie N. Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization. Psychopharmacology. 216: 297-303. PMID 21340469 DOI: 10.1007/S00213-011-2223-6 |
0.47 |
|
| 2011 |
Noble F, Marie N, Puig S, Benturquia N, Marie-Claire C. S.1.04 How neuroadaptation may preclude effective pharmacotherapy for cocaine dependence European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70113-4 |
0.308 |
|
| 2010 |
Mégarbane B, Al-Haddad H, Mohammad W, Marie N, Noble F, Baud F. A comparative study in mice of tolerance to morphine analgesic and respiratory effects: Mechanisms and consequences Toxicology Letters. 196: S90-S91. DOI: 10.1016/J.Toxlet.2010.03.329 |
0.419 |
|
| 2009 |
Belkaï E, Scherrmann JM, Noble F, Marie-Claire C. Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice. Addiction Biology. 14: 245-52. PMID 19523041 DOI: 10.1111/J.1369-1600.2009.00156.X |
0.518 |
|
| 2008 |
Desjardins S, Belkai E, Crete D, Cordonnier L, Scherrmann JM, Noble F, Marie-Claire C. Effects of chronic morphine and morphine withdrawal on gene expression in rat peripheral blood mononuclear cells. Neuropharmacology. 55: 1347-54. PMID 18801381 DOI: 10.1016/J.Neuropharm.2008.08.027 |
0.377 |
|
| 2008 |
Marie-Claire C, Benturquia N, Lundqvist A, Courtin C, Noble F. Characteristics of dual specificity phosphatases mRNA regulation by 3,4-methylenedioxymethamphetamine acute treatment in mice striatum. Brain Research. 1239: 42-8. PMID 18786515 DOI: 10.1016/J.Brainres.2008.08.050 |
0.32 |
|
| 2008 |
Noble F. [Current preclinical knowledge of the neurobiology of cocaine]. Presse MéDicale (Paris, France : 1983). 37: 1767-72. PMID 18768291 DOI: 10.1016/J.Lpm.2008.05.010 |
0.336 |
|
| 2008 |
Benturquia N, Le Marec T, Scherrmann JM, Noble F. Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward. Neuroscience. 155: 341-4. PMID 18571333 DOI: 10.1016/J.Neuroscience.2008.05.015 |
0.415 |
|
| 2008 |
Benturquia N, Courtin C, Noble F, Marie-Claire C. Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice. Brain Research. 1211: 1-5. PMID 18433738 DOI: 10.1016/J.Brainres.2008.03.016 |
0.388 |
|
| 2008 |
Kelai S, Maussion G, Noble F, Boni C, Ramoz N, Moalic JM, Peuchmaur M, Gorwood P, Simonneau M. Nrxn3 upregulation in the globus pallidus of mice developing cocaine addiction. Neuroreport. 19: 751-5. PMID 18418251 DOI: 10.1097/Wnr.0B013E3282Fda231 |
0.326 |
|
| 2008 |
Marie-Claire C, Palminteri S, Romualdi P, Noble F. Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice. Neuropharmacology. 54: 1107-11. PMID 18410947 DOI: 10.1016/J.Neuropharm.2008.03.001 |
0.408 |
|
| 2008 |
Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, Coscas S, Blecha L, Lowenstein W, Martinot JL, Reynaud M, Lépine JP. New treatments for cocaine dependence: a focused review. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 425-38. PMID 17927843 DOI: 10.1017/S1461145707008097 |
0.321 |
|
| 2008 |
Noble F, Benturquia N, Bilkei-Gorzo A, Zimmer A, Roques BP. Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours. Psychopharmacology. 196: 327-35. PMID 17906961 DOI: 10.1007/S00213-007-0964-Z |
0.46 |
|
| 2008 |
Noble F. Respective role of mu and delta opioid receptors in the antidepressant-like effects induced by endogenous opioid peptides enkephalins Journal of Affective Disorders. 107: S35-S36. DOI: 10.1016/j.jad.2007.12.187 |
0.375 |
|
| 2007 |
Benturquia N, Le Guen S, Canestrelli C, Lagente V, Apiou G, Roques BP, Noble F. Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice. Neuroscience. 149: 477-86. PMID 17905521 DOI: 10.1016/J.Neuroscience.2007.08.003 |
0.399 |
|
| 2007 |
Noble F. Pharmacology of CCKRs and SAR studies of peptidic analog ligands. Current Topics in Medicinal Chemistry. 7: 1173-9. PMID 17584139 DOI: 10.2174/156802607780960447 |
0.326 |
|
| 2007 |
Noble F, Sanchez M, Lowenstein W. Interest for delivery of cocaethylene in a sustained release emulsion vs saline evaluated on behavioral sensitization in naive and cocaine-sensitized mice. Psychopharmacology. 193: 415-21. PMID 17476479 DOI: 10.1007/S00213-007-0800-5 |
0.343 |
|
| 2007 |
Cordonnier L, Sanchez M, Roques BP, Noble F. Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments. British Journal of Pharmacology. 151: 94-102. PMID 17351659 DOI: 10.1038/Sj.Bjp.0707195 |
0.492 |
|
| 2007 |
Noble F, Roques BP. Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs. Expert Opinion On Therapeutic Targets. 11: 145-59. PMID 17227231 DOI: 10.1517/14728222.11.2.145 |
0.422 |
|
| 2007 |
Marie-Claire C, Salzmann J, David A, Courtin C, Canestrelli C, Noble F. Rnd family genes are differentially regulated by 3,4-methylenedioxymethamphetamine and cocaine acute treatment in mice brain. Brain Research. 1134: 12-7. PMID 17196187 DOI: 10.1016/J.Brainres.2006.11.065 |
0.37 |
|
| 2007 |
Marie-Claire C, Courtin C, Robert A, Gidrol X, Roques BP, Noble F. Sensitization to the conditioned rewarding effects of morphine modulates gene expression in rat hippocampus. Neuropharmacology. 52: 430-5. PMID 17014870 DOI: 10.1016/J.Neuropharm.2006.08.012 |
0.379 |
|
| 2006 |
Jardinaud F, Roques BP, Noble F. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice. Behavioural Brain Research. 173: 255-61. PMID 16884789 DOI: 10.1016/J.Bbr.2006.06.027 |
0.492 |
|
| 2006 |
Courtin C, Crete D, Canestrelli C, Noble F, Marie-Claire C. Regulation of genes involved in dopamine transporter modulation by acute cocaine in rat striatum. Neuroscience Letters. 398: 235-40. PMID 16459018 DOI: 10.1016/J.Neulet.2006.01.001 |
0.319 |
|
| 2006 |
Mégarbane B, Marie N, Pirnay S, Borron SW, Gueye PN, Risède P, Monier C, Noble F, Baud FJ. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation. Toxicology and Applied Pharmacology. 212: 256-67. PMID 16169027 DOI: 10.1016/J.Taap.2005.08.002 |
0.386 |
|
| 2006 |
Cordonnier L, Sanchez M, Roques B, Noble F. P.6.d.009 Blockade of morphine-induced behavioural sensitization by the association amisulpride-RB101 - comparison with classical opioid maintenance treatments European Neuropsychopharmacology. 16: S512. DOI: 10.1016/S0924-977X(06)70700-3 |
0.333 |
|
| 2005 |
Jardinaud F, Crété D, Canestrelli C, Ledent C, Roques BP, Noble F. CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited. Brain Research. 1063: 77-83. PMID 16256959 DOI: 10.1016/J.Brainres.2005.09.015 |
0.491 |
|
| 2005 |
Nieto MM, Guen SL, Kieffer BL, Roques BP, Noble F. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience. 135: 305-13. PMID 16112476 DOI: 10.1016/J.Neuroscience.2005.06.025 |
0.445 |
|
| 2005 |
Cordonnier L, Sanchez M, Roques BP, Noble F. Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment. Neuroscience. 135: 1-10. PMID 16084652 DOI: 10.1016/J.Neuroscience.2005.06.006 |
0.501 |
|
| 2004 |
Marie-Claire C, Courtin C, Roques BP, Noble F. Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 2208-15. PMID 15199374 DOI: 10.1038/Sj.Npp.1300513 |
0.356 |
|
| 2003 |
Noble F, Roques BP. The role of CCK2 receptors in the homeostasis of the opioid system. Drugs of Today (Barcelona, Spain : 1998). 39: 897-908. PMID 14702135 DOI: 10.1358/Dot.2003.39.11.799467 |
0.489 |
|
| 2003 |
Salzmann J, Marie-Claire C, Le Guen S, Roques BP, Noble F. Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. British Journal of Pharmacology. 140: 831-8. PMID 14517176 DOI: 10.1038/Sj.Bjp.0705506 |
0.379 |
|
| 2003 |
Le Guen S, Mas Nieto M, Canestrelli C, Chen H, Fournié-Zaluski MC, Cupo A, Maldonado R, Roques BP, Noble F. Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone. Pain. 104: 139-48. PMID 12855323 DOI: 10.1016/S0304-3959(02)00486-4 |
0.482 |
|
| 2003 |
Marie-Claire C, Laurendeau I, Canestrelli C, Courtin C, Vidaud M, Roques B, Noble F. Fos but not Cart (cocaine and amphetamine regulated transcript) is overexpressed by several drugs of abuse: a comparative study using real-time quantitative polymerase chain reaction in rat brain. Neuroscience Letters. 345: 77-80. PMID 12821175 DOI: 10.1016/S0304-3940(03)00307-0 |
0.371 |
|
| 2002 |
Benoist JM, Keime F, Montagne J, Noble F, Fournié-Zaluski MC, Roques BP, Willer JC, Le Bars D. Depressant effect on a C-fibre reflex in the rat, of RB101, a dual inhibitor of enkephalin-degrading enzymes. European Journal of Pharmacology. 445: 201-10. PMID 12079685 DOI: 10.1016/S0014-2999(02)01753-3 |
0.319 |
|
| 2002 |
Le Guen S, Noble F, Fournié-Zaluski MC, Roques BP, Besson JM, Buritova J. RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level. European Journal of Pharmacology. 441: 141-50. PMID 12063085 DOI: 10.1016/S0014-2999(01)01497-2 |
0.401 |
|
| 2002 |
Pommier B, Beslot F, Simon A, Pophillat M, Matsui T, Dauge V, Roques BP, Noble F. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2005-11. PMID 11880531 DOI: 10.1523/Jneurosci.22-05-02005.2002 |
0.516 |
|
| 2002 |
Nieto MM, Wilson J, Cupo A, Roques BP, Noble F. Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 1034-41. PMID 11826132 DOI: 10.1523/Jneurosci.22-03-01034.2002 |
0.5 |
|
| 2002 |
Chen H, Noble F, Mothé A, Meudal H, Coric P, Danascimento S, Roques BP, George P, Fournié-Zaluski MC. Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities. Journal of Medicinal Chemistry. 43: 1398-408. PMID 10753476 DOI: 10.1021/Jm990483L |
0.329 |
|
| 2002 |
Pommier B, Nascimento SD, Dumont S, Bellier B, Million E, Garbay C, Roques BP, Noble F. The CholecystokininB Receptor Is Coupled to Two Effector Pathways Through Pertussis Toxin‐Sensitive and ‐Insensitive G Proteins Journal of Neurochemistry. 73: 281-288. PMID 10386981 DOI: 10.1046/J.1471-4159.1999.0730281.X |
0.308 |
|
| 2002 |
Montiel J, Cornille F, Roques BP, Noble F. Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. Journal of Neurochemistry. 68: 354-361. PMID 8978746 DOI: 10.1046/J.1471-4159.1997.68010354.X |
0.357 |
|
| 2001 |
Noble F, Banisadr G, Jardinaud F, Popovici T, Lai-Kuen R, Chen H, Bischoff L, Parsadaniantz SM, Fournie-Zaluski MC, Roques BP. First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [125I]RB 129. Neuroscience. 105: 479-88. PMID 11672613 DOI: 10.1016/S0306-4522(01)00185-3 |
0.352 |
|
| 2001 |
Nieto MM, Wilson J, Walker J, Benavides J, Fournié-Zaluski MC, Roques BP, Noble F. Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management. Neuropharmacology. 41: 496-506. PMID 11543770 DOI: 10.1016/S0028-3908(01)00077-6 |
0.461 |
|
| 2001 |
Valverde O, Noble F, Beslot F, Daugé V, Fournié-Zaluski MC, Roques BP. Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. The European Journal of Neuroscience. 13: 1816-24. PMID 11359533 DOI: 10.1046/J.0953-816X.2001.01558.X |
0.525 |
|
| 2001 |
Mas-Nieto M, Pommier B, Tzavara ET, Caneparo A, Da Nascimento S, Le Fur G, Roques BP, Noble F. Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction. British Journal of Pharmacology. 132: 1809-16. PMID 11309253 DOI: 10.1038/Sj.Bjp.0703990 |
0.515 |
|
| 2000 |
Noble F, Szücs M, Kieffer B, Roques BP. Overexpression of dynamin is induced by chronic stimulation of mu- but not delta-opioid receptors: relationships with mu-related morphine dependence. Molecular Pharmacology. 58: 159-66. PMID 10860938 DOI: 10.1124/Mol.58.1.159 |
0.499 |
|
| 1999 |
Noble F, Roques BP. CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology. Progress in Neurobiology. 58: 349-79. PMID 10368033 DOI: 10.1016/S0301-0082(98)00090-2 |
0.339 |
|
| 1998 |
Chen H, Noble F, Coric P, Fournie-Zaluski MC, Roques BP. Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: a class of central analgesics. Proceedings of the National Academy of Sciences of the United States of America. 95: 12028-33. PMID 9751784 DOI: 10.1073/Pnas.95.20.12028 |
0.373 |
|
| 1998 |
Noble F, Smadja C, Valverde O, Maldonado R, Coric P, Turcaud S, Fournié-Zaluski MC, Roques BP. Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120. Pain. 73: 383-91. PMID 9469529 DOI: 10.1016/S0304-3959(97)00125-5 |
0.4 |
|
| 1998 |
Vincent B, Jiracek J, Noble F, Loog M, Roques B, Dive V, Vincent JP, Checler F. Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation. European Journal of Pharmacology. 334: 49-53. PMID 9346327 DOI: 10.1016/S0014-2999(97)01209-0 |
0.361 |
|
| 1997 |
Vincent B, Jiracek J, Noble F, Loog M, Roques B, Dive V, Vincent JP, Checler F. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation. British Journal of Pharmacology. 121: 705-10. PMID 9208137 DOI: 10.1038/Sj.Bjp.0701182 |
0.336 |
|
| 1997 |
Noble F, Roques BP. Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice. Febs Letters. 401: 227-9. PMID 9013892 DOI: 10.1016/S0014-5793(96)01476-7 |
0.375 |
|
| 1997 |
Roques BP, Noble F. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction. Neurochemical Research. 21: 1397-410. PMID 8947930 DOI: 10.1007/Bf02532381 |
0.465 |
|
| 1997 |
Noble F, Maldonado R, Roques BP. Physiological antagonism between endogenous CCK and opioid: Clinical perspectives in the management of pain Behavioral and Brain Sciences. 20: 460-461. DOI: 10.1017/S0140525X9745149X |
0.432 |
|
| 1997 |
Million M, Lena I, Nascimento SD, Noble F, Dauge V, Garbay C, Roques BP. Development of new potent agonists able to interact with two postulated subsites of the cholecystokinin CCK-B receptor Letters in Peptide Science. 4: 407-410. DOI: 10.1007/Bf02442908 |
0.308 |
|
| 1996 |
Noble F, Fournie-Zaluski M-, Roques BP. Opposite role of δ1- and δ2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for δ-opioid receptor heterogeneity Neuroscience. 75: 917-926. PMID 8951884 DOI: 10.1016/0306-4522(96)00323-5 |
0.49 |
|
| 1996 |
Noble F, Cox BM. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. British Journal of Pharmacology. 117: 161-9. PMID 8825358 DOI: 10.1111/J.1476-5381.1996.Tb15169.X |
0.43 |
|
| 1995 |
Noble F, Cox BM. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen. Journal of Neurochemistry. 65: 125-33. PMID 7790855 DOI: 10.1046/J.1471-4159.1995.65010125.X |
0.317 |
|
| 1995 |
Noble F, Roques BP. Assessment of endogenous enkephalins efficacy in the hot plate test in mice: comparative study with morphine. Neuroscience Letters. 185: 75-8. PMID 7746508 DOI: 10.1016/0304-3940(94)11228-B |
0.443 |
|
| 1995 |
Noble F, Blommaert A, Fournié-Zaluski MC, Roques BP. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test. European Journal of Pharmacology. 273: 145-51. PMID 7737308 DOI: 10.1016/0014-2999(94)00688-4 |
0.486 |
|
| 1994 |
Derrien M, Noble F, Maldonado R, Roques BP. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice. Neuroscience Letters. 160: 193-6. PMID 8247353 DOI: 10.1016/0304-3940(93)90411-D |
0.467 |
|
| 1994 |
Noble F, Coric P, Turcaud S, Fournié-Zaluski MC, Roques BP. Assessment of physical dependence after continuous perfusion into the rat jugular vein of the mixed inhibitor of enkephalin-degrading enzymes, RB 101. European Journal of Pharmacology. 253: 283-7. PMID 8200422 DOI: 10.1016/0014-2999(94)90203-8 |
0.439 |
|
| 1994 |
Noble F, Fournié-Zaluski M-, Roques BP. Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradation. Neuropharmacology. 33: 135-140. PMID 7910383 DOI: 10.1016/0028-3908(94)90108-2 |
0.391 |
|
| 1994 |
Noble F, Coric P, Turcaud S, Fournié-Zaluski M, Roques BP. RB 101, mixed-inhibitor prodrug of enkephalin-degrading enzymes, intra venously infused in rats does not induce development of physical dependence Regulatory Peptides. 53. DOI: 10.1016/0167-0115(94)90273-9 |
0.421 |
|
| 1994 |
Smadja C, Maldonado R, Noble F, Coric P, Roques B. Modulation of antidepressant-like effects induced by endogenous enkephalins through CCK-B receptors Neuropeptides. 26: 23. DOI: 10.1016/0143-4179(94)90188-0 |
0.35 |
|
| 1993 |
Noble F, Fournié-Zaluski MC, Roques BP. Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice. European Journal of Pharmacology. 230: 139-49. PMID 8422896 DOI: 10.1016/0014-2999(93)90796-K |
0.457 |
|
| 1993 |
Noble F, Derrien M, Roques BP. Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain. British Journal of Pharmacology. 109: 1064-70. PMID 8401918 DOI: 10.1111/J.1476-5381.1993.Tb13730.X |
0.482 |
|
| 1993 |
Maldonado R, Derrien M, Noble F, Roques BP. Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses. Neuroreport. 4: 947-50. PMID 8369487 DOI: 10.1097/00001756-199307000-00028 |
0.389 |
|
| 1993 |
Noble F, Coric P, Fournié-Zaluski MC, Roques BP. Lack of physical dependence in mice after repeated systemic administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB101. European Journal of Pharmacology. 223: 91-6. PMID 1478261 DOI: 10.1016/0014-2999(92)90822-L |
0.459 |
|
| 1993 |
Noble F, Turcaud S, Fournié-Zaluski MC, Roques BP. Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine. European Journal of Pharmacology. 223: 83-9. PMID 1478260 DOI: 10.1016/0014-2999(92)90821-K |
0.466 |
|
| 1992 |
Fournié-Zaluski MC, Coric P, Turcaud S, Lucas E, Noble F, Maldonado R, Roques BP. "Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes. Journal of Medicinal Chemistry. 35: 2473-81. PMID 1352352 DOI: 10.1021/Jm00091A016 |
0.376 |
|
| 1991 |
Schmidt C, Peyroux J, Noble F, Fournié-Zaluski MC, Roques BP. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests. European Journal of Pharmacology. 192: 253-62. PMID 2032557 DOI: 10.1016/0014-2999(91)90050-Z |
0.357 |
|
| 1990 |
Baamonde A, Daugé V, Gacel G, Noble F, Feger J, Roques B. Behavioral and analgesic effects of BUBU, a highly selective delta opioid agonist, after peripheral administration European Journal of Pharmacology. 183: 2324-2325. DOI: 10.1016/0014-2999(90)93882-Q |
0.459 |
|
| Show low-probability matches. |